|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.080 USD | -1.42% |
|
-2.35% | +51.82% |
| Market Cap | 72Cr 63Cr 58Cr 54Cr 101.97Cr 6.84TCr 103.52Cr 692.42Cr 269.18Cr 3.36TCr 269.48Cr 263.69Cr 12TCr | P/E 2026 * |
-2.96x | P/E 2027 * | -2.77x |
|---|---|---|---|---|---|
| Enterprise Value | 53Cr 47Cr 43Cr 40Cr 76Cr 5.07TCr 77Cr 513.33Cr 199.56Cr 2.49TCr 199.78Cr 195.49Cr 8.58TCr | EV / Sales 2026 * |
88,706x | EV / Sales 2027 * | 47.6x |
| Free-Float |
83.53% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Allogene Therapeutics, Inc.
| 1 day | -1.42% | ||
| 1 week | -2.35% | ||
| 1 month | +4.00% | ||
| 3 months | -16.13% | ||
| 6 months | +54.07% | ||
| Current year | +51.82% |
| 1 week | 2.03 |  | 2.25 |
| 1 month | 1.75 | | 2.25 |
| Current year | 1.31 | | 4.46 |
| 1 year | 0.98 | | 4.46 |
| 3 years | 0.86 | | 6.05 |
| 5 years | 0.86 | | 27.86 |
| 10 years | 0.86 | | 55 |
| Manager | Title | Age | Since |
|---|---|---|---|
Zachary Roberts
CEO | Chief Executive Officer | 48 | 01/07/2026 |
Geoffrey Parker
DFI | Director of Finance/CFO | 61 | 16/10/2023 |
Benjamin Beneski
CTO | Chief Tech/Sci/R&D Officer | 49 | 28/02/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Arie Belldegrun
CHM | Chairman | 76 | 01/11/2017 |
Joshua Kazam
BRD | Director/Board Member | 49 | 01/11/2017 |
Franz Humer
BRD | Director/Board Member | 79 | 01/04/2018 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 18/06 | Free | Director | 95,400 | 0.0276% | ||
| 18/06 | Fiscal year | Founder | 1,90,800 | 0.0553% | ||
| 18/06 | Free | Director | 1,44,400 | 0.0418% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.42% | -2.35% | +74.79% | -58.06% | 72Cr | |
| +0.68% | +5.92% | +80.45% | +137.78% | 5.91TCr | |
| +2.32% | +5.03% | +75.51% | +94.88% | 5.52TCr | |
| +3.86% | +6.93% | -11.32% | -9.53% | 2.47TCr | |
| +4.30% | +7.95% | +14.11% | +437.83% | 2.42TCr | |
| +4.74% | +13.68% | +45.58% | -1.42% | 1.97TCr | |
| -0.29% | +9.78% | +44.62% | -27.94% | 1.76TCr | |
| 0.00% | +20.78% | +178.93% | +360.74% | 1.62TCr | |
| +3.50% | +1.97% | +21.02% | +191.95% | 1.4TCr | |
| +6.72% | +19.38% | +42.82% | - | 1.48TCr | |
| Average | +2.44% | +7.81% | +56.65% | +125.14% | 2.46TCr | |
| Weighted average by Cap. | +2.45% | +6.46% | +59.10% | +137.10% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 6T 5.25T 4.82T 4.49T 8.52T 6L 8.65T 57.87T 22.5T 3L 22.52T 22.04T 10L | 1.3Cr 1.13Cr 1.04Cr 97.15L 1.84Cr 123.52Cr 1.87Cr 13Cr 4.86Cr 61Cr 4.87Cr 4.77Cr 209.23Cr |
| Net income | -20Cr -17Cr -16Cr -15Cr -28Cr -1.87TCr -28Cr -189.59Cr -74Cr -920Cr -74Cr -72Cr -3.17TCr | -23Cr -20Cr -18Cr -17Cr -32Cr -2.16TCr -33Cr -219.08Cr -85Cr -1.06TCr -85Cr -83Cr -3.66TCr |
| Net Debt | -19Cr -16Cr -15Cr -14Cr -26Cr -1.77TCr -27Cr -179.09Cr -70Cr -869.06Cr -70Cr -68Cr -2.99TCr | -10Cr -8.81Cr -8.1Cr -7.55Cr -14Cr -959.73Cr -15Cr -97Cr -38Cr -471.76Cr -38Cr -37Cr -1.63TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/26/02 | $2.080 | -1.42% | 91,36,319 |
| 01/26/01 | $2.110 | +1.44% | 1,29,19,981 |
| 30/26/30 | $2.080 | -6.31% | 1,79,82,796 |
| 29/26/29 | $2.220 | +4.23% | 1,46,63,951 |
| 26/26/26 | $2.130 | +3.40% | 2,59,19,246 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ALLO Stock
Select your edition
All financial news and data tailored to specific country editions
